Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System Software Recall
Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System Software
FDA recall Class II
Ongoing
FDA lists this Class II recall for Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System Software. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2239-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jul 17, 2025
- FDA report date
- Aug 13, 2025
- Quantity in commerce
- 149 Serial Numbers
- Distribution
- See key details
- FDA cause
- Software change control
What is being recalled?
Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System Software
Affected model & UDI checker
Search the exact identifiers published for Z-2239-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System Software | Check source notice | 00884838103566 |
FDA code information
Software Version Number: 18.0.5/UDI: (01)00884838103566
Why was this product recalled?
Due to software issue, Radiation Therapy Planning system may provide incorrect dataset calculations when performing the "Stopping Power Ratio" (SPR) ,
What actions did Philips Medical Systems (Cleveland) Inc take?
On July 17, 2025, Philips issued a "Urgent Medical Device Correction" Notification to affected consignees. Philips asked consignees to take the following actions: 1. You may continue to use your system(s) in accordance with the intended use and by following the recommendations below. 2. To prevent the issue from occurring, when using SPR generation, always verify data sets are from same acquisition and matching reconstruction parameters. 3. Ensure that relevant clinical staff, including physicians, physicists, and dosimetrists, are informed about the potential for incorrect dataset calculations due to mixing of data sets 4D CT spectral and SPR generation. 4. Circulate this notice to all users of this device so that they are aware of the potential issue. Please retain this letter with your system(s) until a solution is installed on your system; ensure the letter is in a place likely to be seen/viewed. 5. Please complete and return the attached response form to Philips promptly and no later than 30 days from receipt of this letter via email to: Philips.recall@philips.com
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2239-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology